Nomination Committee appointed for Bactiguard Holding AB’s Annual General Meeting 2025
The Nomination Committee for the Annual General Meeting of Bactiguard Holding AB (publ), to be held on Thursday 15 May 2025 in Stockholm, has been appointed. The Nomination Committee will consist of:
- Helena Borglund (appointed by TomBact AB)
- Christian Kinch (appointed by GIDL Invest AB)
- Jan Ståhlberg (appointed by Jan Ståhlberg)
- Mats J Andersson (appointed by Nordea Fonder)
- Jannis Kitsakis (appointed by Fjärde AP Fonden)
In accordance with the instructions for the Nomination Committee in Bactiguard Holding AB (publ), the Nomination Committee shall consist of five members. The Chairman of the Board of Directors shall contact the largest shareholders of the company, in terms of voting power, pursuant to Euroclear Sweden AB’s print out of the share register on 31 August. Each of the largest shareholders shall be offered the opportunity to, within reasonable time, appoint a member.
The Nomination Committee will make proposals to the Annual General Meeting 2025 concerning the election of a Chairman for the Annual General Meeting, the Chairman and other members of the Board of Directors, as well as auditors. The Nomination Committee will also make proposals regarding remuneration to the Board of Directors, including any separate remuneration for committee work, as well as remuneration to the auditors. Further, the Nomination Committee will make a proposal regarding principles for forming the Nomination Committee for the Annual General Meeting in 2026.
Shareholders who wish to make proposals to the Nomination Committee can do so by writing to the Nomination Committee under the following address:
Nomination Committee Bactiguard Holding AB (publ)
P O Box 15
S - 146 21 Tullinge
Proposals can also be sent by email to the following address: valberedningen@bactiguard.com
In order for the Nomination Committee to be able to address proposals in a constructive manner, they should have been received by January 15, 2025. The proposals of the Nomination Committee will be presented in the invitation to the Annual General Meeting and on the company’s website.
For further information, please contact:
Patrick Bach, CFO +46 761 295 911
Nina Nornholm, Head of Communications & Investor Relations +46 708 550 356
About Bactiguard
Bactiguard is a global MedTech company developing safe and biocompatible technology to prevent medical device related infections. The company’s unique technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. Bactiguard’s infection prevention technology and solutions decrease patient suffering, save lives, and unburden healthcare resources while also fighting against antimicrobial resistance, one of the most serious threats to global health and modern medicine.Bactiguard operates through license partnerships with leading global MedTech companies that apply the technology to their medical devices and sell them under their own brand or co-branded with Bactiguard. The company also has a portfolio of wound management products. Bactiguard is headquartered in Stockholm and listed on Nasdaq Stockholm.
Read more about Bactiguard: www.bactiguard.com
Follow Bactiguard on LinkedIn